Authors:
UPLEKAR M
JUVEKAR S
MORANKAR S
RANGAN S
NUNN P
Citation: M. Uplekar et al., TUBERCULOSIS PATIENTS AND PRACTITIONERS IN PRIVATE CLINICS IN INDIA, The international journal of tuberculosis and lung disease, 2(4), 1998, pp. 324-329
Citation: S. Rangan et Rg. Sloan, IMPLICATIONS OF THE INTEGRAL APPROACH TO QUARTERLY REPORTING FOR THE POST-EARNINGS-ANNOUNCEMENT DRIFT, The Accounting review, 73(3), 1998, pp. 353-371
Citation: S. Rangan et K. Poolla, WEIGHTED OPTIMIZATION FOR MULTIOBJECTIVE FULL-INFORMATION CONTROL-PROBLEMS, Systems & control letters, 31(4), 1997, pp. 207-213
Citation: S. Rangan et K. Poolla, TIME-DOMAIN VALIDATION FOR SAMPLE-DATA UNCERTAINTY MODELS, IEEE transactions on automatic control, 41(7), 1996, pp. 980-991
Citation: S. Rangan et B. Leung, QUANTIZATION NOISE SPECTRUM OF DOUBLE-LOOP SIGMA-DELTA CONVERTER WITHSINUSOIDAL INPUT, IEEE transactions on circuits and systems. 2, Analog and digital signal processing, 41(2), 1994, pp. 168-173
Authors:
JAPOUR AJ
MAYERS DL
JOHNSON VA
KURITZKES DR
BECKETT LA
ARDUINO JM
LANE J
BLACK RJ
REICHELDERFER PS
DAQUILA RT
CRUMPACKER CS
BALFOUR H
ERICE A
COOMBS R
KATZENSTEIN D
LATHEY J
RICHMAN D
MCINTOSH K
RANGAN S
REICHMAN R
SCOTT W
USSERY M
ABRAMS L
MCCUTCHAN F
BURKE D
GARDNER L
ROBERTS C
CHUNG R
HICKS C
SHELLIE E
FOWLER A
MERRITT L
FUJIMURAJUSTICE M
RUIZ N
WAGNER K
GAIL M
Citation: Aj. Japour et al., STANDARDIZED PERIPHERAL-BLOOD MONONUCLEAR CELL-CULTURE ASSAY FOR DETERMINATION OF DRUG SUSCEPTIBILITIES OF CLINICAL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES, Antimicrobial agents and chemotherapy, 37(5), 1993, pp. 1095-1101
Citation: S. Rangan et Rz. Lawrence, THE RESPONSES OF UNITED-STATES FIRMS TO EXCHANGE-RATE FLUCTUATIONS - PIERCING THE CORPORATE VEIL, Brookings papers on economic activity, (2), 1993, pp. 341-379